A 12 Week, Phase II Trial of the Safety, Pharmacokinetics, and Efficacy of INV-144 Compared With Losartan Potassium in Patients With Hypertension and Type 2 Diabetes Mellitus With Nephropathy.
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2012
At a glance
- Drugs Losartan; Losartan/thioctic-acid
- Indications Diabetic nephropathies; Hypertension; Type 2 diabetes mellitus
- Focus Adverse reactions
- 06 Aug 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.